Skip to main content
US EQUITIES PRE-MARKET CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
LI

LIVNStockLivaNova PLC

Nasdaq Global Select Market · Healthcare · GB

$94.54 last close 2026-11-18
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment LIVN's does — no target price to set, unlike a price alert.

Stable Ratio screen, 7 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it

Sharia status
COMPLIANT
Per our in-house ratio engine · assessed 2026-08-28
7 of 7 pass our own screen — all 7 agree here
Purification 1.35% *HTR non-permissible income 1.37%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🟡 BULLISH LEAN
The main driver: outperforming the market by 24.0%. More signals pointing up than down. Not full confluence yet, but...
Scores: 3 bullish / 0 bearish
30
of 100
Setup confidence — system conviction, not win probabilityF

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure2 of 5 timeframes bullish · 21.7% aligned
VWAPPrice holding above VWAP ($92.68)
VolumeRelative volume 4.0× the 20-day average
Momentum10-day rate of change -1.1%
Overall readBULLISH LEAN

LivaNova PLC (LIVN) is currently considered halal (Sharia-compliant), per our in-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Price target
$105.09
+11.2% · 11 analysts
Institutional own.
115.8% *
of shares
Momentum (10d)
-1.1%
rate of change
SMC grade
F · 30
21.7% aligned
1.35% *
Purification ratio (secondary provider, uncertain)
1.37%
Non-permissible income — HTR, from filings (2025-12-31)
F · 30
SMC grade — 21.7% timeframe alignment
-1.1%
Rate of change (10d)
$105.09
Price target (+11.2%) · 11 analysts
115.8%
Institutional ownership *

How the status reached this point

Compliant · status tracked since Nov 17, 2026

No change to LIVN’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from our own screen, last on Nov 18, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $5.1B as of 2026-11-18.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 6.98% 30.00% Pass(23.0pp buffer)
Interest-bearing investments 11.13% 30.00% Pass(18.9pp buffer)
Non-permissible income 1.37% 5.00% Pass(3.6pp buffer)
Usmani Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 13.02% 33.00% Pass(20.0pp buffer)
Interest-bearing investments 20.77% 33.00% Pass(12.2pp buffer)
Non-liquid assets 70.52% at least 20.00% Pass(50.5pp above the floor)
Non-permissible income 1.37% 5.00% Pass(3.6pp buffer)
MSCI Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 13.02% 33.33% Pass(20.3pp buffer)
Cash + interest-bearing securities 20.77% 33.33% Pass(12.6pp buffer)
Accounts receivable 29.48% 33.33% Pass(3.8pp buffer)
Non-permissible income 1.37% 5.00% Pass(3.6pp buffer)
FTSE Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 10.89% 33.33% Pass(22.4pp buffer)
Cash + interest-bearing securities 20.77% 33.33% Pass(12.6pp buffer)
Accounts receivable 29.48% 50.00% Pass(20.5pp buffer)
Non-permissible income 1.37% 5.00% Pass(3.6pp buffer)
Dow Jones Islamic Market Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 11.17% 33.00% Pass(21.8pp buffer)
Cash + interest-bearing securities 17.82% 33.00% Pass(15.2pp buffer)
Accounts receivable 7.47% 33.00% Pass(25.5pp buffer)
Non-permissible income 1.37% 5.00% Pass(3.6pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 11.73% 33.00% Pass(21.3pp buffer)
Cash + interest-bearing securities 18.70% 49.00% Pass(30.3pp buffer)
Accounts receivable 7.85% 49.00% Pass(41.2pp buffer)
Non-permissible income 1.37% 5.00% Pass(3.6pp buffer)
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 11.73% 33.33% Pass(21.6pp buffer)
Cash + interest-bearing securities 18.70% 33.33% Pass(14.6pp buffer)
Accounts receivable 26.55% 49.00% Pass(22.5pp buffer)
Non-permissible income 1.37% 5.00% Pass(3.6pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

AAOIFI Standard 21 (% of market cap)non permissible income ratio 3.6pts
Usmani (% of total assets)non permissible income ratio 3.6pts
Dow Jones Islamic Market (% of 24-mo avg market cap)non permissible income ratio 3.6pts

The numbers the ratios are built from

Read from LIVN's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $1.4B 2025-12-31 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $295.4M 2026-09-30 LongTermDebtNoncurrent, LongTermDebtCurrent
Cash and interest-bearing securitiesCash, equivalents and marketable securities $563.5M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $2.7B 2026-09-30 Assets
Market capDenominator for AAOIFI $5.1B live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $3.1B 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $3.3B 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $19.0M 2025-12-31 InvestmentIncomeInterest

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-04, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-02-25, period ended 2025-12-31. Screened 2026-11-18.

  • Total assets$2.7B
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Interest-bearing debt$295.4M
    LongTermDebtNoncurrent $295.2M · period ended 2026-09-30 · 10-Q filed 2026-11-04
    LongTermDebtCurrent $190.0K · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Cash and interest-bearing securities$563.5M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Receivables$236.4M
    AccountsReceivableNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Revenue$1.4B
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2025-12-31 · 10-K filed 2026-02-25
  • Interest income (non-permissible)$19.0M
    InvestmentIncomeInterest · period ended 2025-12-31 · 10-K filed 2026-02-25
  • Market cap$5.1B
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link

7 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for LIVN. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-18 Unverified → Pass filing re-screen

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 7 pass and 0 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-18.

No standard's deciding ratio sits within 3 points of its line.

The ratios that move with the share price

AAOIFI's debt ratio (7.0% against a 30% line) would only fail if the market cap fell by 77%, to $1.2B.

AAOIFI's investments ratio (11.1% against a 30% line) would only fail if the market cap fell by 63%, to $1.9B.

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Medical Devices listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
ABTAbbott Laboratories $201.9B —
SYKStryker Corp. $125.7B —
MDTMedtronic Plc $117.8B —
BSXBoston Scientific Corp. $71.0B —
EWEdwards Lifesciences Corp $52.2B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold LIVN

10 of the 203 funds whose filed holdings we currently hold own LIVN shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns LIVN.

You may already own it

Widely held U.S. index funds. If you own one, you own LIVN through it. None of them is a Shariah fund; the last column is our look-through of each.

FundLIVN in fundFund compliant by weight
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.01% 54%
SCHB Schwab U.S. Broad Market ETF 0.01% 53%
Other funds
FundLIVN in fundFund compliant by weight
JPSV JPMorgan Active Small Cap Value ETF 1.72% 30%
MVSSX Victory Integrity Small-Cap Value Fund 1.07% 28%
FCPGX Fidelity Small Cap Growth Fund 0.25% 45%
VSEMX VANGUARD EXTENDED MARKET INDEX FUND 0.05% 42%
VLU State Street(R) SPDR(R) S&P(R) 1500 Value Tilt ETF 0.00% 35%
VTWAX VANGUARD TOTAL WORLD STOCK INDEX FUND 0.00% 50%
DFSVX U.S. SMALL CAP VALUE PORTFOLIO 0.00% 21%
JAFEX Total Stock Market Index Trust 0.00% 52%

Sorted by LIVN’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names LIVN once, so a bond is not counted as the shares; 1 more fund name LIVN in a way we cannot separate from its bonds, and is not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

94.5484.2673.9863.7053.422025-11-192026-05-212026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
89.14
S2
90.39
S1
91.15
PIVOT
92.40
R1
93.16
R2
94.41
R3
95.17

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
69.82 – 81.06
±7.46% from 75.44, made 2026-09-26 · resolves 2026-10-03
STRONG SELL
from 19 indicators
78.7% of our last 25417 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.4% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG BUY
19 indicators
OscillatorsSTRONG BUY
3 buy · 4 neutral · 0 sell
Moving averagesSTRONG BUY
12 buy · 0 neutral · 0 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)69.50NEUTRAL
Stochastic %K (14)76.92NEUTRAL
CCI (20)80.12NEUTRAL
Williams %R (14)-23.08NEUTRAL
MACD (12,26,9)0.51BUY
ROC (10)0.37BUY
Momentum (10)0.35BUY
EMA (10)90.82BUY
SMA (10)91.63BUY
EMA (20)87.73BUY
SMA (20)86.73BUY
EMA (30)85.66BUY
SMA (30)83.63BUY
EMA (50)83.37BUY
SMA (50)81.07BUY
EMA (100)80.31BUY
SMA (100)80.81BUY
EMA (200)74.63BUY
SMA (200)74.58BUY

About LivaNova PLC

Healthcare · Medical Devices

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.

livanova.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Verdict

🟡 BULLISH LEAN

The main driver: outperforming the market by 24.0%. More signals pointing up than down. Not full confluence yet, but the weight of evidence is bullish. Use `!alert LIVN [level]` to catch the entry, or `!plan LIVN` to size small.

Scores: 3 bullish / 0 bearish

Grade verdict

No real edge — avoid

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily RANGING 64
⏰ 4H RANGING 38
🕐 1H BULLISH 98
⏱ 15-Min RANGING 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-1.1%
Rate of change (10d)
4.0×
Volume vs its 20-day average
3.62
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.